Ritter Pharmaceuticals Reports Top-Line Results from its Liberatus Phase 3 Trial of RP-G28 for Lactose Intolerance

September 12, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search